Nagase, H. et al. 2021. Effects of compound-326, a selective delta-5 desaturase inhibitor, in ApoE knockout mice with two different protocols for atherosclerosis development. Journal of Pharmacy & Pharmaceutical Sciences. 24, (Feb. 2021), 71–83. DOI:https://doi.org/10.18433/jpps31389.